| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Malaria, Falciparum | 14 | 2023 | 91 | 5.960 |
Why?
|
| Antibodies, Protozoan | 12 | 2023 | 82 | 4.060 |
Why?
|
| Antigens, Protozoan | 11 | 2023 | 74 | 4.010 |
Why?
|
| Plasmodium falciparum | 11 | 2023 | 146 | 3.800 |
Why?
|
| Campylobacter jejuni | 11 | 2009 | 22 | 2.260 |
Why?
|
| Plasmids | 12 | 2009 | 247 | 2.200 |
Why?
|
| Conjugation, Genetic | 11 | 2008 | 14 | 1.970 |
Why?
|
| Helicobacter pylori | 12 | 2010 | 116 | 1.820 |
Why?
|
| Drug Resistance, Bacterial | 12 | 2017 | 88 | 1.820 |
Why?
|
| Escherichia coli Proteins | 8 | 2010 | 133 | 1.480 |
Why?
|
| Escherichia coli | 13 | 2010 | 461 | 1.170 |
Why?
|
| Bacterial Proteins | 14 | 2017 | 580 | 1.150 |
Why?
|
| Tetracycline Resistance | 6 | 2007 | 6 | 1.150 |
Why?
|
| Antibody Affinity | 2 | 2020 | 21 | 1.140 |
Why?
|
| Fucosyltransferases | 5 | 2006 | 9 | 1.100 |
Why?
|
| Immunoglobulin G | 6 | 2023 | 253 | 1.090 |
Why?
|
| Placenta | 4 | 2023 | 113 | 0.970 |
Why?
|
| Membrane Proteins | 6 | 2008 | 548 | 0.950 |
Why?
|
| R Factors | 4 | 2005 | 4 | 0.930 |
Why?
|
| Premature Birth | 2 | 2023 | 94 | 0.850 |
Why?
|
| Infant | 8 | 2023 | 1143 | 0.830 |
Why?
|
| Anti-Bacterial Agents | 5 | 2007 | 415 | 0.810 |
Why?
|
| Carrier Proteins | 7 | 2008 | 318 | 0.790 |
Why?
|
| Merozoite Surface Protein 1 | 4 | 2022 | 34 | 0.780 |
Why?
|
| Immunoglobulin M | 4 | 2022 | 87 | 0.760 |
Why?
|
| Macrolides | 3 | 2007 | 14 | 0.760 |
Why?
|
| Campylobacter coli | 3 | 2006 | 3 | 0.740 |
Why?
|
| Pregnancy | 8 | 2023 | 1737 | 0.730 |
Why?
|
| DNA, Bacterial | 8 | 2017 | 207 | 0.730 |
Why?
|
| Malaria | 1 | 2022 | 90 | 0.720 |
Why?
|
| Pregnancy Complications, Parasitic | 2 | 2018 | 10 | 0.720 |
Why?
|
| Cameroon | 8 | 2019 | 35 | 0.710 |
Why?
|
| Parasitemia | 2 | 2018 | 13 | 0.710 |
Why?
|
| Campylobacter Infections | 4 | 2006 | 8 | 0.600 |
Why?
|
| Protozoan Proteins | 2 | 2018 | 196 | 0.590 |
Why?
|
| Infant, Newborn | 5 | 2023 | 960 | 0.570 |
Why?
|
| Pregnancy Outcome | 1 | 2018 | 92 | 0.550 |
Why?
|
| Disease Susceptibility | 1 | 2018 | 101 | 0.540 |
Why?
|
| High-Throughput Screening Assays | 1 | 2017 | 72 | 0.530 |
Why?
|
| Endemic Diseases | 1 | 2017 | 22 | 0.520 |
Why?
|
| Erythrocytes | 1 | 2017 | 126 | 0.520 |
Why?
|
| RNA, Ribosomal, 16S | 4 | 2005 | 190 | 0.490 |
Why?
|
| Sulfadoxine | 1 | 2015 | 6 | 0.490 |
Why?
|
| Pyrimethamine | 1 | 2015 | 10 | 0.490 |
Why?
|
| Humans | 31 | 2023 | 42163 | 0.480 |
Why?
|
| Monocytes | 1 | 2017 | 275 | 0.470 |
Why?
|
| Antimalarials | 1 | 2015 | 63 | 0.460 |
Why?
|
| Temperature | 6 | 2017 | 314 | 0.450 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2015 | 112 | 0.430 |
Why?
|
| Diagnostic Tests, Routine | 3 | 2019 | 51 | 0.420 |
Why?
|
| Mutation | 7 | 2017 | 1169 | 0.410 |
Why?
|
| Molecular Sequence Data | 11 | 2005 | 1559 | 0.410 |
Why?
|
| Tellurium | 3 | 2003 | 5 | 0.400 |
Why?
|
| Young Adult | 9 | 2020 | 4936 | 0.400 |
Why?
|
| Microbial Sensitivity Tests | 8 | 2017 | 232 | 0.400 |
Why?
|
| Female | 13 | 2023 | 24018 | 0.380 |
Why?
|
| Erythromycin | 3 | 2007 | 14 | 0.370 |
Why?
|
| Gene Transfer, Horizontal | 3 | 2009 | 24 | 0.370 |
Why?
|
| Bacteria | 2 | 2006 | 285 | 0.370 |
Why?
|
| Adult | 11 | 2022 | 13458 | 0.360 |
Why?
|
| Base Sequence | 8 | 2017 | 997 | 0.360 |
Why?
|
| Ribosomes | 4 | 2005 | 34 | 0.330 |
Why?
|
| Polymerase Chain Reaction | 5 | 2019 | 454 | 0.320 |
Why?
|
| Merozoites | 2 | 2020 | 3 | 0.310 |
Why?
|
| Epitopes | 1 | 2010 | 155 | 0.310 |
Why?
|
| Immunoassay | 2 | 2020 | 69 | 0.300 |
Why?
|
| Salmonella typhi | 1 | 2009 | 33 | 0.300 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2009 | 15 | 0.300 |
Why?
|
| Adolescent | 8 | 2020 | 5950 | 0.300 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2009 | 29 | 0.300 |
Why?
|
| Transcription, Genetic | 3 | 2008 | 599 | 0.300 |
Why?
|
| Intestines | 1 | 2009 | 71 | 0.290 |
Why?
|
| Cell Membrane | 2 | 2008 | 400 | 0.280 |
Why?
|
| Interleukin-6 | 1 | 2009 | 165 | 0.280 |
Why?
|
| Fucose | 1 | 2006 | 4 | 0.260 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2007 | 83 | 0.260 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2007 | 58 | 0.260 |
Why?
|
| Carbohydrate Metabolism | 1 | 2006 | 26 | 0.250 |
Why?
|
| Liver Abscess | 1 | 2006 | 3 | 0.250 |
Why?
|
| Campylobacter | 1 | 2006 | 2 | 0.250 |
Why?
|
| Epithelial Cells | 2 | 2010 | 426 | 0.250 |
Why?
|
| Child, Preschool | 5 | 2019 | 1516 | 0.250 |
Why?
|
| Poultry | 1 | 2006 | 10 | 0.250 |
Why?
|
| Cloning, Molecular | 5 | 2004 | 318 | 0.240 |
Why?
|
| Subcellular Fractions | 1 | 2005 | 79 | 0.240 |
Why?
|
| Tetracyclines | 1 | 2005 | 2 | 0.240 |
Why?
|
| Catalytic Domain | 1 | 2006 | 118 | 0.240 |
Why?
|
| Plants | 1 | 2006 | 114 | 0.230 |
Why?
|
| Tyrosine | 1 | 2005 | 119 | 0.230 |
Why?
|
| DNA Primers | 4 | 2007 | 295 | 0.230 |
Why?
|
| Helicobacter Infections | 2 | 2005 | 84 | 0.230 |
Why?
|
| Serratia marcescens | 1 | 2004 | 3 | 0.230 |
Why?
|
| Diarrhea | 1 | 2005 | 95 | 0.220 |
Why?
|
| Site-Specific DNA-Methyltransferase (Adenine-Specific) | 1 | 2004 | 3 | 0.220 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 2004 | 7 | 0.220 |
Why?
|
| Mutagenesis, Site-Directed | 4 | 2005 | 189 | 0.220 |
Why?
|
| Virulence Factors | 1 | 2005 | 119 | 0.220 |
Why?
|
| Molecular Biology | 1 | 2004 | 47 | 0.220 |
Why?
|
| Kanamycin Resistance | 1 | 2004 | 1 | 0.210 |
Why?
|
| Nucleotides | 1 | 2004 | 37 | 0.210 |
Why?
|
| Protein Structure, Tertiary | 3 | 2015 | 427 | 0.210 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2008 | 293 | 0.210 |
Why?
|
| Male | 9 | 2020 | 22779 | 0.210 |
Why?
|
| Immunity, Maternally-Acquired | 1 | 2022 | 12 | 0.200 |
Why?
|
| Middle Aged | 7 | 2020 | 11819 | 0.200 |
Why?
|
| Adenosine Triphosphatases | 1 | 2003 | 83 | 0.200 |
Why?
|
| Antibody Formation | 1 | 2022 | 75 | 0.200 |
Why?
|
| Escherichia coli O157 | 1 | 2002 | 17 | 0.190 |
Why?
|
| Child | 5 | 2019 | 3381 | 0.190 |
Why?
|
| Microscopy | 2 | 2019 | 33 | 0.180 |
Why?
|
| Operon | 3 | 2008 | 43 | 0.180 |
Why?
|
| Amino Acid Sequence | 4 | 2005 | 1188 | 0.180 |
Why?
|
| Two-Hybrid System Techniques | 3 | 2007 | 51 | 0.180 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2006 | 271 | 0.170 |
Why?
|
| Substrate Specificity | 3 | 2006 | 217 | 0.160 |
Why?
|
| Gene Expression Regulation, Bacterial | 3 | 2005 | 168 | 0.150 |
Why?
|
| Sulfhydryl Compounds | 1 | 1999 | 49 | 0.150 |
Why?
|
| Blood | 1 | 2019 | 37 | 0.150 |
Why?
|
| Luminescent Proteins | 3 | 2004 | 65 | 0.150 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 456 | 0.150 |
Why?
|
| Antigens, Bacterial | 1 | 1999 | 144 | 0.150 |
Why?
|
| Transformation, Bacterial | 3 | 2005 | 12 | 0.150 |
Why?
|
| Infant, Low Birth Weight | 1 | 2018 | 36 | 0.140 |
Why?
|
| Green Fluorescent Proteins | 3 | 2004 | 207 | 0.140 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 3 | 2008 | 198 | 0.140 |
Why?
|
| Aged | 5 | 2019 | 7982 | 0.140 |
Why?
|
| Aged, 80 and over | 3 | 2019 | 2803 | 0.140 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2018 | 72 | 0.140 |
Why?
|
| Genotype | 3 | 2017 | 796 | 0.140 |
Why?
|
| Rifampin | 1 | 2017 | 8 | 0.140 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 2017 | 28 | 0.140 |
Why?
|
| Sequence Analysis, DNA | 4 | 2003 | 508 | 0.140 |
Why?
|
| Antitubercular Agents | 1 | 2017 | 33 | 0.140 |
Why?
|
| Microspheres | 1 | 2017 | 49 | 0.140 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2017 | 196 | 0.130 |
Why?
|
| Phagocytosis | 1 | 2017 | 83 | 0.130 |
Why?
|
| Recombinant Proteins | 2 | 2010 | 522 | 0.130 |
Why?
|
| RNA, Ribosomal, 23S | 2 | 2007 | 5 | 0.130 |
Why?
|
| Saliva | 1 | 2017 | 115 | 0.130 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2017 | 106 | 0.130 |
Why?
|
| Lipopolysaccharides | 2 | 2010 | 235 | 0.130 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 512 | 0.120 |
Why?
|
| Flow Cytometry | 1 | 2017 | 411 | 0.120 |
Why?
|
| Bacterial Typing Techniques | 2 | 2006 | 36 | 0.120 |
Why?
|
| Immunoprecipitation | 2 | 2007 | 128 | 0.120 |
Why?
|
| Protein Conformation | 3 | 2008 | 420 | 0.120 |
Why?
|
| Placenta Diseases | 1 | 2015 | 5 | 0.120 |
Why?
|
| Insecticide-Treated Bednets | 1 | 2015 | 8 | 0.120 |
Why?
|
| Parity | 1 | 2015 | 60 | 0.120 |
Why?
|
| Drug Administration Schedule | 1 | 2015 | 153 | 0.120 |
Why?
|
| Open Reading Frames | 2 | 2008 | 81 | 0.120 |
Why?
|
| Drug Combinations | 1 | 2015 | 102 | 0.120 |
Why?
|
| Cell Line | 3 | 2010 | 1416 | 0.110 |
Why?
|
| Amino Acid Substitution | 2 | 2005 | 135 | 0.110 |
Why?
|
| Biological Transport | 2 | 2007 | 201 | 0.110 |
Why?
|
| Immunoblotting | 2 | 2006 | 181 | 0.110 |
Why?
|
| Virulence | 2 | 2005 | 238 | 0.110 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 1058 | 0.110 |
Why?
|
| Sequence Alignment | 2 | 2004 | 273 | 0.100 |
Why?
|
| Kinetics | 2 | 2006 | 698 | 0.100 |
Why?
|
| Genetic Complementation Test | 2 | 2003 | 57 | 0.100 |
Why?
|
| Microbial Viability | 2 | 2017 | 42 | 0.100 |
Why?
|
| Case-Control Studies | 1 | 2015 | 1266 | 0.090 |
Why?
|
| Cross-Sectional Studies | 2 | 2019 | 3077 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2004 | 649 | 0.090 |
Why?
|
| Animals | 6 | 2009 | 16695 | 0.090 |
Why?
|
| Ligases | 1 | 2010 | 8 | 0.080 |
Why?
|
| Glycosyltransferases | 1 | 2010 | 9 | 0.080 |
Why?
|
| Papua New Guinea | 1 | 2010 | 21 | 0.080 |
Why?
|
| Colombia | 1 | 2010 | 30 | 0.080 |
Why?
|
| Cross Reactions | 1 | 2010 | 86 | 0.080 |
Why?
|
| Protein Biosynthesis | 2 | 2008 | 136 | 0.080 |
Why?
|
| Gene Frequency | 1 | 2010 | 203 | 0.080 |
Why?
|
| Caco-2 Cells | 1 | 2009 | 59 | 0.070 |
Why?
|
| Retrospective Studies | 1 | 2015 | 2485 | 0.070 |
Why?
|
| Alleles | 1 | 2010 | 352 | 0.070 |
Why?
|
| Peptide Elongation Factor G | 1 | 2008 | 1 | 0.070 |
Why?
|
| Cosmids | 1 | 2008 | 2 | 0.070 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 2008 | 17 | 0.070 |
Why?
|
| Evolution, Molecular | 1 | 2010 | 299 | 0.070 |
Why?
|
| Gastric Mucosa | 2 | 2010 | 64 | 0.070 |
Why?
|
| Clarithromycin | 1 | 2007 | 9 | 0.070 |
Why?
|
| Dipeptides | 1 | 2007 | 31 | 0.070 |
Why?
|
| Guanosine Triphosphate | 1 | 2007 | 18 | 0.070 |
Why?
|
| Culture Media | 1 | 2007 | 96 | 0.070 |
Why?
|
| Scattering, Radiation | 1 | 2007 | 43 | 0.070 |
Why?
|
| Circular Dichroism | 1 | 2007 | 64 | 0.070 |
Why?
|
| Hydrolysis | 1 | 2007 | 98 | 0.070 |
Why?
|
| Chromosomes, Bacterial | 1 | 2007 | 21 | 0.070 |
Why?
|
| Protein Transport | 1 | 2008 | 295 | 0.070 |
Why?
|
| Solubility | 1 | 2007 | 134 | 0.060 |
Why?
|
| Models, Molecular | 3 | 2008 | 875 | 0.060 |
Why?
|
| Light | 1 | 2007 | 182 | 0.060 |
Why?
|
| Binding Sites | 2 | 2005 | 670 | 0.060 |
Why?
|
| Chromatography, Liquid | 1 | 2007 | 173 | 0.060 |
Why?
|
| MutS DNA Mismatch-Binding Protein | 1 | 2005 | 1 | 0.060 |
Why?
|
| United States | 1 | 2017 | 5072 | 0.060 |
Why?
|
| Oligosaccharides | 1 | 2006 | 28 | 0.060 |
Why?
|
| Species Specificity | 1 | 2006 | 279 | 0.060 |
Why?
|
| Point Mutation | 1 | 2005 | 98 | 0.060 |
Why?
|
| Replicon | 1 | 2004 | 7 | 0.060 |
Why?
|
| Salmonella enterica | 1 | 2004 | 9 | 0.060 |
Why?
|
| Kanamycin Kinase | 1 | 2004 | 2 | 0.060 |
Why?
|
| Alberta | 1 | 2004 | 2 | 0.060 |
Why?
|
| Kanamycin | 1 | 2004 | 5 | 0.060 |
Why?
|
| DNA Gyrase | 1 | 2004 | 7 | 0.060 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2004 | 90 | 0.060 |
Why?
|
| Colony Count, Microbial | 1 | 2004 | 67 | 0.060 |
Why?
|
| RNA, Bacterial | 1 | 2004 | 38 | 0.050 |
Why?
|
| Bacterial Adhesion | 1 | 2004 | 40 | 0.050 |
Why?
|
| Coliphages | 1 | 2004 | 9 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2006 | 457 | 0.050 |
Why?
|
| Sweden | 1 | 2004 | 17 | 0.050 |
Why?
|
| Restriction Mapping | 1 | 2004 | 45 | 0.050 |
Why?
|
| Genetic Vectors | 1 | 2004 | 165 | 0.050 |
Why?
|
| Quinolines | 1 | 2004 | 76 | 0.050 |
Why?
|
| Egypt | 1 | 2004 | 53 | 0.050 |
Why?
|
| Cattle | 1 | 2005 | 505 | 0.050 |
Why?
|
| Peptide Fragments | 1 | 2006 | 301 | 0.050 |
Why?
|
| Food Microbiology | 1 | 2004 | 38 | 0.050 |
Why?
|
| Geography | 1 | 2004 | 107 | 0.050 |
Why?
|
| Proteus mirabilis | 1 | 2003 | 2 | 0.050 |
Why?
|
| Canada | 1 | 2004 | 157 | 0.050 |
Why?
|
| Lac Repressors | 1 | 2003 | 8 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2009 | 1066 | 0.050 |
Why?
|
| Golgi Apparatus | 1 | 2003 | 28 | 0.050 |
Why?
|
| Macromolecular Substances | 1 | 2003 | 95 | 0.050 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2003 | 20 | 0.050 |
Why?
|
| Protein Binding | 2 | 2005 | 1076 | 0.050 |
Why?
|
| Tetracycline | 1 | 2003 | 17 | 0.050 |
Why?
|
| DNA Damage | 1 | 2005 | 358 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 1 | 2005 | 534 | 0.050 |
Why?
|
| DNA Repair | 1 | 2004 | 196 | 0.050 |
Why?
|
| Shiga Toxin | 1 | 2002 | 5 | 0.050 |
Why?
|
| Data Interpretation, Statistical | 1 | 2003 | 126 | 0.050 |
Why?
|
| Oxidation-Reduction | 2 | 2005 | 448 | 0.050 |
Why?
|
| Metronidazole | 1 | 2002 | 16 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2005 | 557 | 0.050 |
Why?
|
| Genes, Reporter | 1 | 2002 | 148 | 0.050 |
Why?
|
| Viral Proteins | 1 | 2003 | 196 | 0.040 |
Why?
|
| Phenotype | 2 | 2017 | 774 | 0.040 |
Why?
|
| Repressor Proteins | 1 | 2003 | 267 | 0.040 |
Why?
|
| Electrophoresis, Capillary | 1 | 1999 | 20 | 0.040 |
Why?
|
| Protein Disulfide-Isomerases | 1 | 1999 | 12 | 0.040 |
Why?
|
| Drug Resistance, Microbial | 1 | 1999 | 26 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2009 | 2111 | 0.040 |
Why?
|
| Models, Biological | 1 | 2003 | 711 | 0.040 |
Why?
|
| Time Factors | 1 | 2003 | 1848 | 0.040 |
Why?
|
| Isoniazid | 1 | 2017 | 6 | 0.040 |
Why?
|
| Tuberculosis, Multidrug-Resistant | 1 | 2017 | 6 | 0.040 |
Why?
|
| Genes, Bacterial | 1 | 2017 | 92 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 602 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 236 | 0.030 |
Why?
|
| Models, Statistical | 1 | 2017 | 190 | 0.030 |
Why?
|
| Paraquat | 2 | 2005 | 21 | 0.030 |
Why?
|
| Hydrogen Peroxide | 2 | 2005 | 193 | 0.030 |
Why?
|
| Prevalence | 1 | 2017 | 1597 | 0.020 |
Why?
|
| O Antigens | 1 | 2010 | 7 | 0.020 |
Why?
|
| Transferases (Other Substituted Phosphate Groups) | 1 | 2010 | 6 | 0.020 |
Why?
|
| Peptidyl Transferases | 1 | 2010 | 3 | 0.020 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2010 | 31 | 0.020 |
Why?
|
| Glycosylation | 1 | 2010 | 111 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2008 | 884 | 0.010 |
Why?
|
| Oxidants | 1 | 2005 | 43 | 0.010 |
Why?
|
| Mutagenesis, Insertional | 1 | 2005 | 35 | 0.010 |
Why?
|
| Carbohydrate Sequence | 1 | 2005 | 20 | 0.010 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2005 | 54 | 0.010 |
Why?
|
| Guanine | 1 | 2005 | 45 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2005 | 168 | 0.010 |
Why?
|
| Oxygen | 1 | 2005 | 217 | 0.010 |
Why?
|
| Bacterial Vaccines | 1 | 2005 | 129 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2005 | 300 | 0.010 |
Why?
|
| Gastric Acidity Determination | 1 | 2003 | 3 | 0.010 |
Why?
|
| Molecular Structure | 1 | 2005 | 560 | 0.010 |
Why?
|
| Peptide Elongation Factor 2 | 1 | 2003 | 5 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2003 | 98 | 0.010 |
Why?
|
| Mice | 2 | 2005 | 6490 | 0.010 |
Why?
|
| DNA | 1 | 2005 | 594 | 0.010 |
Why?
|
| Molecular Conformation | 1 | 2002 | 157 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2005 | 1804 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2005 | 1554 | 0.010 |
Why?
|